Many studies showed that NHWD-870 treatment significantly decreased the amount of c-Myc and p53 expression, suggesting that this may be one method NHWD-870 inhibits renal fibrosis and necrosis [23-25]. The gene discussed is TP53; the disease is renal fibrosis.